What Scienza Health does

Scienza Health, Inc. is a private voice AI and speech biomarker health technology company founded in 2024 and headquartered in Newport Beach, California. It builds GIA®, an FDA-registered digital human that autonomously conducts multimodal screening conversations with patients via video, voice, or landline to assess 46 cognitive, neurological, and behavioral conditions in approximately 40 seconds, with results surfaced for clinician review in under two minutes. The platform runs on digitalhumanOS™, a multimodal operating system that fuses voice AI, computer vision (facial micro-expression and movement-disorder analysis), and speech biomarker analysis against a proprietary dataset of 12.3M+ post-acute care patients, 27B+ longitudinal clinical events, and 3M+ neurodegenerative patient journeys, with disclosed condition-level AUC benchmarks ranging from 0.874 to 0.97.

The company serves skilled nursing facilities, regional multi-facility operators, medical directors, directors of nursing, primary care physicians, neurologists, and geriatricians, with an adjacent workforce behavioral health channel for employers and EAP providers. Its go-to-market combines a direct enterprise sales motion (demos, free pilots) with two anchor distribution channels: a native PointClickCare Marketplace listing (launched March 2026 at HIMSS) granting access to 14,600+ post-acute facilities, and an OEM-embedded Samsung Galaxy device ecosystem partnership (October 2025) that pre-bundles GIA on Health Grade Galaxy hardware secured by Samsung Knox. Bidirectional HL7 FHIR and direct API integrations connect GIA to PointClickCare, Epic, Cerner, MatrixCare, Netsmart, and American HealthTech EHRs.

Scienza Health generates revenue primarily through quote-based annual or multi-year SaaS subscriptions to skilled nursing facilities and healthcare organizations, with pricing not publicly disclosed. A secondary value lever is CPT-coded documentation generated from screening outputs (codes 96127, 96146, 99483, G0444, G0438, G0439) that supports clinician reimbursement, though coding decisions remain with clinicians. The company is seed-funded, with $535,000 raised in September 2024 and an ongoing seed round disclosed via its careers page; headcount stands at six people as of the latest source, with expansion explicitly tied to seed-round close.

Name

Scienza Health

Legal name

Scienza Health, Inc.

Website

https://scienzahealth.com

Company type

Private

Founded year

2024

Operating status

Operating

Headcount range

11–50 employees

Short description

Scienza Health builds GIA®, an FDA-registered multimodal AI co-clinician that autonomously screens post-acute and long-term care patients for 46 cognitive, neurological, and behavioral conditions from a 40-second conversation, serving skilled nursing facilities, clinicians, and regional operators through EHR-integrated SaaS subscriptions.

Ownership category

akta.pro rank

Product category

Healthcare Clinical AI Screening Software

NAICS

Custom Computer Programming Services (541511), Computer Systems Design and Related Services (54151)

SIC

Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Post-Acute & Hospital-at-Home Remote Care Platforms (HLACAFAB)

akta.pro secondary industries

Virtual Nursing, Telemonitoring & Command Center Platforms (HLACAFAH), Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways) (HLACAFAO), Medical Imaging AI (HDAAAEAH)

Keywords

• Clinical AI screening
• Speech biomarker analysis
• Post-acute care software
• EHR-integrated screening
• AI co-clinician platform

Headquarters

HQ city

Newport Beach

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Enterprise SaaS Subscription: Annual or multi-year subscription model for skilled nursing facilities and healthcare organizations accessing GIA platform through PointClickCare Marketplace or direct sales. Pricing is quote-based, not publicly disclosed.
2. CPT Code Reimbursement Support: Platform generates documentation supporting CPT codes including 96127 (brief behavioral assessment), 96146 (automated test administration), 99483 (cognitive assessment and care plan), G0444 (annual depression screening), and G0438/G0439 (annual wellness visit). Clinicians order, review, and approve results; coding decisions remain with clinicians.

Pricing tiers

Go-to-market motion4 records

Distribution channels4 records

Marketing channels6 records

Core offering

Scienza Health sells an enterprise SaaS platform centered on GIA®, an FDA-registered AI Co-Clinician that autonomously conducts 40-second conversational screenings for 46 cognitive, neurological, and behavioral conditions, then writes structured results, ICD-10 codes, clinical notes, transcripts, and patient video back to the EHR via HL7 FHIR and direct API. The platform is powered by digitalhumanOS™, a multimodal operating system combining Voice AI, Computer Vision, and Speech Biomarker analysis, and is sold as annual or multi-year subscriptions to skilled nursing facilities, multi-facility operators, and enterprise healthcare organizations, with distribution through the PointClickCare Marketplace and Samsung Galaxy device ecosystem.

Product overview

Scienza Health offers a platform-plus-modules architecture centered on GIA®, the first commercially deployed AI co-clinician for cognitive and behavioral health, and digitalhumanOS™, the underlying multimodal clinical screening operating system. GIA® is a digital human that autonomously conducts screening conversations via video, voice, or landline to detect 46 cognitive, neurological, and behavioral conditions using speech biomarkers, computer vision, and ambient sensor capture from Samsung Galaxy devices. The platform automates the complete screening workflow from order through EHR write-back to follow-up, with every result requiring clinician review before entry. The portfolio includes the core GIA® screening product, the digitalhumanOS™ governance platform, the GIA® Cognitive Risk Score Dashboard for clinical intelligence, and a Workforce Behavioral Health Screening module for employer/EAP deployments. The platform is peer-reviewed across 19 published studies and integrates natively with PointClickCare, Epic, Cerner, MatrixCare, and Samsung Galaxy devices.

Differentiator

Problem solved

Functional benefit

Brands

• GIA®: AI Co-Clinician - the world's first cleared digital human for clinical screening, conducting cognitive, neurological, and behavioral screening across 46 conditions
• digitalhumanOS™
• Digital Human®

Products and services

• GIA® (Generative Intelligent Assistant) AI Co-Clinician FDA-registered AI Co-Clinician that autonomously conducts 40-second screening conversations with patients via video, voice, or landline to screen for 46 cognitive, neurological, and behavioral conditions. Results are reviewed by a clinician before EHR entry. Targets skilled nursing facilities, multi-facility operators, medical directors, primary care physicians, neurologists, and geriatricians in post-acute and long-term care settings.
• digitalhumanOS™ Multimodal Clinical Screening Operating System Multimodal operating system powering GIA® that processes Voice AI, Computer Vision, and Speech Biomarker analysis in real time during patient screening conversations. Includes a 5-layer governance framework with human-in-the-loop review, HIPAA-compliant audit trail, role-based access control, automated escalation logic, and continuous bias and drift monitoring. Sells to enterprise healthcare organizations seeking a clinical AI platform with regulatory-compliant governance.
• GIA® Workforce Behavioral Health Screening Workforce behavioral health screening offering that extends GIA® screening technology to employers, EAP providers, and health plans. Screens for depression, anxiety, PTSD, burnout, and substance use indicators; integrates with HR platforms including Workday, ADP, Rippling, BambooHR, Paychex, TriNet, and Gusto via REST API. No PHI returned to employer.

Quantifiable outcome

• 1 in 3 patients leave with undetected condition (NEJM); 47% of clinician time spent on documentation (AMA); $28B lost annually to missed diagnoses in post-acute care (Johns Hopkins/BMJ)
• +3 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration20 records

AI capability13 records

Feature7 records

Partnerships

Seven partnerships are on record, tiered core, flagship and minor.

• PointClickCarecoreChannel Partner/ Reseller/ Distributor · 9 March 2026PointClickCare Marketplace listing provides access to 14,600+ post-acute and long-term care facilities. Native HL7 FHIR and API integration enables real-time bidirectional EHR write-back of screening results, structured medical notes, transcripts, and patient video. Deployment completes in under 30 minutes with no middleware required.
• Samsung Electronics AmericaflagshipTechnology or Integration · 22 October 2025Strategic technology partnership making GIA accessible across Samsung Galaxy device ecosystem including phones, tablets, watches, and TVs through web-based platform. Samsung Health Grade Galaxy devices secured by Samsung Knox with hardware-level security. Ambient and biometric signal capture via Galaxy Watch and Samsung Health platform.
• EpiccoreTechnology or IntegrationEHR integration partner enabling bidirectional data flow with Epic's electronic health record system through HL7 FHIR and direct API connections.
• CernercoreTechnology or IntegrationEHR integration partner enabling bidirectional data flow with Cerner's electronic health record system through HL7 FHIR and direct API connections.
• MatrixCarecoreTechnology or IntegrationEHR integration partner enabling bidirectional data flow with MatrixCare's electronic health record system through HL7 FHIR and direct API connections.
• Google DeepMindminorStrategic or Co-development PartnerGIA aligned with Google DeepMind's published 'AI co-clinician' / triadic care research (May 2026 announcement titled 'Towards Conversational Medical AI with Eyes, Ears and a Voice'). Scienza Health's platform predates and independently implements similar architecture.
• Academic Medical CenterscoreStrategic or Co-development PartnerIndependent peer-reviewed clinical validation at academic medical centers across 19 published studies in major medical journals including The Lancet, validating speech biomarker science for cognitive and behavioral screening.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Winterlight Labs: Speech biomarker analysis platform for cognitive assessment, including dementia, Alzheimer's, and CNS disorders. Closely comparable technology approach (speech-based biomarkers) and clinical endpoints to GIA's multimodal screening.
• Ellipsis Health: Voice-based behavioral health assessment using AI to detect depression, anxiety, and other mental health conditions from speech. Closely comparable in voice biomarker analysis and behavioral health screening use cases.
• Cambridge Cognition: Digital health technology company specializing in cognitive assessments for clinical trials and healthcare. Comparable in peer-reviewed cognitive assessment and CNS disorder screening across healthcare and research customers.
• Linus Health: Digital cognitive assessment platform combining speech, drawing, and gait analysis for early detection of cognitive impairment. Directly comparable in speech-biomarker-based cognitive screening and target customer base of primary care and specialty clinicians.
• BrainCheck: Digital cognitive testing platform used by clinicians for concussion, dementia, and ADHD assessment. Directly competes in the cognitive screening category with similar physician-facing workflow and EHR integration model.
• Cogstate: Cognitive assessment technology used in clinical trials, healthcare, and research with computerized batteries for cognition. Comparable as a peer-reviewed cognitive screening platform, though primarily positioned in clinical trials and research settings.

Broad incumbents

• Suki AI: AI-powered clinical assistant and ambient scribe for physicians that automates documentation and clinical workflow. Broader incumbent in AI clinical automation with overlapping EHR write-back and clinician workflow integration capabilities.

Emerging players

• Altoida: Digital cognitive assessment platform using AR and AI for early detection of Alzheimer's and other neurodegenerative diseases. Comparable in cognitive screening with multimodal AI inputs, though focused on AR-based digital biomarkers.
• NeuroLex Labs: Voice biomarker platform analyzing speech for health conditions including depression, anxiety, and cognitive decline. Comparable in speech-biomarker technology and disease-screening applications, with overlap in clinical research customers.

Regional players

• Biofourmis: AI-driven remote patient monitoring and hospital-at-home platform combining wearable data with clinical analytics. Comparable in AI-powered continuous patient monitoring and post-acute care use cases, though focused on physiological rather than speech/cognitive biomarkers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/ScienzaHealth
• Facebookfacebook.com/profile.php

Compliance12 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Scienza Health